All PlansAdministrativeMedium impact
Recall: Albuterol Sulfate
UPMC Health Plan·Family Medicine, Internal Medicine, Pediatrics +3 more·Pharmacy
We identified it
Jun 20, 2026
Summary
Cipla US has recalled six batches of Albuterol Sulfate Inhalation Aerosol (90 mcg, 200 metered inhalations) manufactured in November 2021 due to inhaler valve leakage issues. This affects patients using this medication for asthma treatment and exercise-induced asthma prevention.
Action Required
Immediately: Clinical staff should identify patients who may have the recalled Albuterol Sulfate batches from November 2021 and contact them to discontinue use. Providers should prescribe alternative albuterol inhalers and document the medication change in patient records. Billing team should be prepared for potential increased prescription and visit volume related to medication replacements.